Moolec Science S.A. (MLEC) - מכפיל EV/EBITDA

The market dynamics of Moolec Science SA (MLEC) securities, where the EV/EBITDA ratio stands at 0.00, correlate with the anticipation of regulatory approvals that currently limit price control. The business generates revenue by granting usage rights for molecular protein synthesis methods in legume crops. Reducing component costs relative to traditional analogs will enable the company to establish its own pricing power for its innovative products.

This indicator compares the total enterprise value (market capitalization plus net debt) to operating profit before depreciation and amortization, allowing for an assessment of the real value of assets regardless of the tax regime. By analyzing the current EV/EBITDA multiple of Moolec Science SA (MLEC), an investor can determine the efficiency of the company's capital expenditures on the development of breakthrough molecular farming technologies for synthesizing animal proteins in plants.